A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants

NCT04960124 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Hepatic Impairment

Interventions

DRUG: JNJ-42847922

Sponsor

Janssen Research & Development, LLC